In Japan, three tumor markers (TMs), namely, alpha-fetoprotein (AFP), fucosylated AFP (AFP-L3), and des gamma-carboxy prothrombin (DCP), can be used not only for surveillance of HCC, but also for assessment of the malignant potential of HCC in Japan. This evidence concerns the gene AFP and neoplasm.